“Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population”, Journal of Pharmaceutical Negative Results, pp. 209–212, Oct. 2022, doi: 10.47750/pnr.2022.13.S02.29.